Nancy M. Ruiz M.D., FACP, FIDSA

Chief Medical Officer at MEDA Pharmaceuticals. Exceptional strategic & scientific leader with experienced oversight of R&D, Regulatory & Medical Affairs, Pharmacovigilance, Clinical Operations, HEOR, Quality Affairs and Project Management. Demonstrated experience in therapeutic area strategy, portfolio management, clinical research, drug development, and medical affairs in Immunology, Infectious Diseases, Allergy/Respiratory, Women's Health and Consumer Health. Outstanding appreciation of business, regulatory and development needs. Global hands-on experience in all phases of drug development, medical affairs, & vast experience interacting with worldwide regulatory authorities - Japan, Europe, U.S, Canada, and Latin America Well established among key opinion leaders, scientists, and industry leaders worldwide and respected as a sound scientist and clinician. Distinguished as an adaptable problem solver and proactive manager with strong interpersonal skills, and proven record of transforming underproductive and under-motivated groups into high-performing teams. Numerous accomplishments include the design and implementation of the registrational clinical development plan of (efavirenz/Sustiva/Stocrin) Project leader HCV(Boceprevir/Victrelis), and demonstrated versatility by leading several development projects in the fields of Infectious Diseases and Immunology. Bilingual (English/Spanish, French competency) media expert with exceptional public relations skills and proficiency presenting to international scientific congresses. scientific panels, senior management, potential investors and Board of Directors. Recognized as a leader by several publications, including named among the 100 Most Influential Hispanics by Hispanic Business and one of the Top 10 Latinas in 2000 by Latina Magazine and have been the recipient of multiple performance awards including the President’s Award at BMS and the 2009 Tribute to Women and Industry award from Schering Plough. Specialties:1. Clinical Development & Medical Affairs (Phase I-IV) 2. Immunology and Infectious Diseases 3. Intercompany Clinical Integration 4. Business Development & Due Dilligence 5. Alliance Management/ Joint Steering Committee Head